citric acid, anhydrous has been researched along with Hyperglycemia in 5 studies
Citric Acid: A key intermediate in metabolism. It is an acid compound found in citrus fruits. The salts of citric acid (citrates) can be used as anticoagulants due to their calcium chelating ability.
citric acid : A tricarboxylic acid that is propane-1,2,3-tricarboxylic acid bearing a hydroxy substituent at position 2. It is an important metabolite in the pathway of all aerobic organisms.
Hyperglycemia: Abnormally high BLOOD GLUCOSE level.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nonalcoholic fatty liver disease (NAFLD) and its evolution to inflammatory steatohepatitis (NASH) are the most common causes of chronic liver damage and transplantation that are reaching epidemic proportions due to the upraising incidence of metabolic syndrome, obesity, and diabetes." | 1.56 | Inhibition of the mitochondrial citrate carrier, Slc25a1, reverts steatosis, glucose intolerance, and inflammation in preclinical models of NAFLD/NASH. ( Albanese, C; Avantaggiati, ML; Catalina-Rodriguez, O; Cheema, A; Foley, P; Gadre, S; Giaccone, G; Graham, GT; Kallakury, B; Kasprzyk-Pawelec, A; Mosaoa, R; Parasido, E; Tan, M; Yi, C, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tan, M | 1 |
| Mosaoa, R | 1 |
| Graham, GT | 1 |
| Kasprzyk-Pawelec, A | 1 |
| Gadre, S | 1 |
| Parasido, E | 1 |
| Catalina-Rodriguez, O | 1 |
| Foley, P | 1 |
| Giaccone, G | 1 |
| Cheema, A | 1 |
| Kallakury, B | 1 |
| Albanese, C | 1 |
| Yi, C | 1 |
| Avantaggiati, ML | 1 |
| Bryland, A | 1 |
| Wieslander, A | 1 |
| Carlsson, O | 1 |
| Hellmark, T | 1 |
| Godaly, G | 1 |
| Bosakowski, T | 1 |
| Levin, AA | 1 |
| Katsumoto, H | 2 |
| Murakoso, K | 2 |
| Sato, Y | 1 |
| Kobayashi, K | 2 |
| Matsuoka, A | 2 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Prospective Randomized Multicenter Study to Demonstrate the Benefits of Hemodialysis Without Acetate (With Citrate): ABC-treat Study[NCT03319680] | 90 participants (Anticipated) | Interventional | 2016-05-31 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 other studies available for citric acid, anhydrous and Hyperglycemia
| Article | Year |
|---|---|
Inhibition of the mitochondrial citrate carrier, Slc25a1, reverts steatosis, glucose intolerance, and inflammation in preclinical models of NAFLD/NASH.
Topics: Acetyl Coenzyme A; Animals; Blood Glucose; Carrier Proteins; Cell Polarity; Citric Acid; Diet, High- | 2020 |
Citrate treatment reduces endothelial death and inflammation under hyperglycaemic conditions.
Topics: Anti-Inflammatory Agents; Apoptosis; Blotting, Western; Cell Survival; Cells, Cultured; Citric Acid; | 2012 |
Comparative acute toxicity of chlorocitrate and fluorocitrate in dogs.
Topics: Adenosine Triphosphate; Animals; Body Temperature; Citrates; Citric Acid; Citric Acid Cycle; Dogs; E | 1987 |
[Fluorometric determination of serum citric acid in diabetic patients with hyperglycemia].
Topics: Citrates; Citric Acid; Diabetes Mellitus; Fluorometry; Humans; Hyperglycemia | 1987 |
Glucose interferes in fluorometry of serum citrate in diabetic patients with hyperglycemia.
Topics: Blood Glucose; Citrates; Citric Acid; Diabetes Complications; Diabetes Mellitus; Fluorometry; Humans | 1987 |